Using NLP to Find “Hidden” Patients for Clinical Trials
Interview on Ontada research presented at ISPOR 2024.
Can RWD Sources Estimate OS in Oncology Research?
Chart Abstraction Pilot Improves Data Accuracy
A New Framework for Handling Missing Data as RWD Sources Rise
IVBM Austin: Value-Based Care in the Modern Era of Cancer Therapy
Coverage from the Institute for Value-Based Medicine.
June 2024 Health Equity News
Collaborative Solutions Are Needed to Address and Mitigate America’s Drug Shortages
How Thyme Care Drives Reductions in Drug Spend in the Enhancing Oncology Model
Whither CAR T? Will the FDA Being Under the Hood and the Availability of Bispecifics Make These Therapies Less Attractive?
CMS Reopens EOM With Payment Boost, Extends Model to 2030
The Enhancing Oncology Model (EOM) attracted fewer participants than its predecessor, with lower payment rates cited as a chief factor.
Wave of Antibody-Drug Conjugates Poised to Change Treatment Paradigms Across Multiple Cancers
Aiwu Ruth He, MD, PhD, Discusses 3-Year Survival Data for Durvalumab Plus Chemo in Biliary Tract Cancer, Other Advances
Bringing the Human Factor to the “Last Mile” of AI-Assisted Clinical Decisions
Implementing Treatment Escalation Plans in Oncology Care at Admission Boosts Uptake, Study Finds
